Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.

By R. Al-Lamee, D. Thompson, Hakim-Moulay Dehbi, S. Sen, K. Tang, J. Davies, Thomas R. Keeble, Michael Mielewczik, R. Kaprielian, I. Malik and 30 more. The Lancet, 2018

821 citations recorded by the source corpus.

Subfields: Anesthesiology and Pain Medicine, Radiology, Nuclear Medicine and Imaging, Surgery

View Paper: https://www.semanticscholar.org/paper/1ba069c9f4a819503735daa7ca8abdcbd69f9200

Citations in the corpus

• 2018 ESC/EACTS Guidelines on myocardial revascularization. (2019, neutral): “[Canadian Cardiovascular Society (CCS) class II in 59% of patients, duration 9 months] for the first time.(63) After 6 weeks of medication optimization (mean number of anti-anginal drugs: 3) and baseline car-”